Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00347568 · ClinicalTrials.gov registry record · NA
BC-DAISY: A Breast Cancer Decision Aid System
A NA study, sponsored by Rhode Island Hospital.
- Completed
- Registry status
- NA
- Development phase
- 195
- Enrollment target
NCT00347568 is a NA study that has completed, run by Rhode Island Hospital. The registered enrollment target is 195 participants.
The verdict
NCT00347568, a NA study, has completed, sponsored by Rhode Island Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 195 participants
- Enrollment target
Study Summary
The purpose of this study is to develop a web-based decision aid to help women at high risk for breast cancer make informed breast cancer prevention choices. These choices include chemoprevention, surgery, genetic counseling, or regular screening in accordance with recommended guidelines.
Interventions
- DEVICE TX-plore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 195 participants |
| Start Date | 2006-07 |
| Est. Completion | 2009-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00347568
The ClinicalTrials.gov registry entry for NCT00347568 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 195 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rhode Island Hospital, which has 130 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which TX-plore is the first listed.
NCT00347568 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00347568 about?
NCT00347568 is a clinical study titled "BC-DAISY: A Breast Cancer Decision Aid System". The purpose of this study is to develop a web-based decision aid to help women at high risk for breast cancer make informed breast cancer prevention choices. These choices include chemoprevention, surgery, genetic counseling, or regular screening in accordance with recommended guidelines.
What is the current status of trial NCT00347568?
This trial is currently completed. It is a NA study. The enrollment target is 195 participants. The study started on 2006-07. Estimated completion is 2009-12.
What interventions are being tested in trial NCT00347568?
The interventions under investigation include: TX-plore (DEVICE).
Who is sponsoring clinical trial NCT00347568?
This trial is sponsored by Rhode Island Hospital, which has 130 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.